Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
Titel:
Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
Auteur:
Sandborn, William J. Danese, Silvio Leszczyszyn, Jaroslaw Romatowski, Jacek Altintas, Engin Peeva, Elena Hassan-Zahraee, Mina Vincent, Michael S. Reddy, Padmalatha S. Banfield, Christopher Salganik, Mikhail Banerjee, Anindita Gale, Jeremy D. Hung, Kenneth E.